Apoptosis
Apoptosis inhibitors are compounds that prevent or delay the process of programmed cell death, known as apoptosis. These inhibitors are vital in studying cell survival mechanisms and are used to investigate diseases where apoptosis is dysregulated, such as cancer, neurodegenerative disorders, and autoimmune diseases. By modulating apoptosis, these inhibitors can help in the development of therapies aimed at controlling cell death. At CymitQuimica, we provide a comprehensive selection of high-quality apoptosis inhibitors to support your research in cell biology, oncology, and related fields.
Subcategories of "Apoptosis"
- ASK(9 products)
- BCL(1 products)
- Caspase(154 products)
- FOXO1(2 products)
- IAP(67 products)
- Mdm2(12 products)
- PD-1/PD-L1(126 products)
- PDK(9 products)
- PERK(23 products)
- Serine/threonin kinase(17 products)
- Survivin(14 products)
- TNF(91 products)
- c-RET(61 products)
- p53(63 products)
Show 6 more subcategories
Found 6170 products of "Apoptosis"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
RET-IN-16
CAS:RET-IN-16: Selective RET inhibitor, IC50s 3.98-15.05 nM for various RET mutations; anticancer properties.Formula:C31H29F3N8O2Color and Shape:SolidMolecular weight:602.61SEC
CAS:SEC triggers ANXA7 GTPase via AMPK/mTORC1/STAT3, causing ITGB4-driven apoptosis in ITGB4-high cancer cells.Formula:C22H23ClN2O5Color and Shape:SolidMolecular weight:430.88FD223
CAS:FD223, a PI3Kδ inhibitor, is highly potent (IC50=1 nM) and selective, limiting AML cell growth by causing G1 arrest.Formula:C17H12ClN5O2SColor and Shape:SolidMolecular weight:385.83CAY10773
CAS:CAY10773, a sorafenib derivative, inhibits cancer cells over non-cancerous ones and induces apoptosis or ferroptosis in T24 cells.Formula:C22H17Cl2N5OColor and Shape:SolidMolecular weight:438.31Topoisomerase IIα-IN-3
CAS:Topoisomerase IIα-IN-3 is a DNA-inserting topoisomerase-Iiα inhibitor that blocks the cell cycle in G0/G1 phase and induces apoptosis.Formula:C29H20N6O2SColor and Shape:SolidMolecular weight:516.57FAK-IN-5
CAS:FAK-IN-5 is a FAK signaling inhibitor that induces apoptosis and autophagy.Formula:C29H29ClF3N3O4Color and Shape:SolidMolecular weight:576.01ANO1-IN-3
CAS:ANO1-IN-3 (Compound 3n) can induces apoptosis that is a potent and selective inhibitor of ANO1 with an IC 50 of 1.23 μM [1].Formula:C20H17NO3Color and Shape:SolidMolecular weight:319.35HS-438
CAS:HS-438 inhibits imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.Formula:C17H17N3O3SColor and Shape:SolidMolecular weight:343.4Anti-inflammatory agent 17
CAS:Compound 17: Orally active, potent IL-6 & TNF-α inhibitor; not cytotoxic; promising for ALI research.Formula:C20H23NO5Color and Shape:SolidMolecular weight:357.4SCAL-255
CAS:SCAL-255 is a mitochondrial complex I (CI) inhibitor, exhibiting potent inhibition with an IC50 of 1.14 μM.Formula:C27H28F3N5O3Purity:98%Color and Shape:SolidMolecular weight:527.54Rohinitib
CAS:Rohinitib, an eIF4A inhibitor, triggers apoptosis in AML cells and lessens tumor load in models.Formula:C29H31NO8Color and Shape:SolidMolecular weight:521.56SKI-I
CAS:SKI-I: Human sphingosine kinase inhibitor, IC50 1.2μM; hERK2 inhibitor, IC50 11μM; promotes tumor cell apoptosis.Formula:C25H18N4O2Color and Shape:SolidMolecular weight:406.44SID 3712249
CAS:SID 3712249 is an inhibitor of the biogenesis of microRNA-544 (miR-544).Formula:C17H21N7Purity:98%Color and Shape:SolidMolecular weight:323.4PD-1/PD-L1-IN-28
CAS:PD-1/PD-L1-IN-28, an inhibitor of the PD-1/PD-L1 signaling pathway (IC 50 = 0.744 µM), demonstrates promising research potential in tumor immunity.Formula:C24H24N4O2Color and Shape:SolidMolecular weight:400.47JMX0293
JMX0293, a salicylamide derivative, inhibits STAT3, inducing MDA-MB-231 cell apoptosis with IC50=3.38μM, while sparing MCF-10A (IC50>60μM).Formula:C25H30Cl2N4O7Color and Shape:SolidMolecular weight:569.43MMP-9-IN-3
CAS:MMP-9-IN-3: MMP-9/AKT inhibitor (IC50: 5.56/2.11 nM), forms H-bonds, cytotoxic, induces apoptosis, used in cancer research.Formula:C29H25N3O4Color and Shape:SolidMolecular weight:479.53ZMF-10
CAS:ZMF-10 inhibits PAK1 (IC50: 174 nM), PAK2, PAK3; affects apoptosis, ER stress, migration in cancer studies.Formula:C19H17F6N7OColor and Shape:SolidMolecular weight:473.38αβ-Tubulin-IN-1
CAS:αβ-Tubulin-IN-1 is a potent and orally active inhibitor of αβ-Tubulin.Formula:C25H19N3O3Color and Shape:SolidMolecular weight:409.44MX107
CAS:MX107 is a survivin inhibitor which induces degradation of XIAP and/or cIAP1, and suppresses genotoxic NF-kappaB activation.Formula:C24H28N2O2Color and Shape:SolidMolecular weight:376.49HDAC-IN-51
HDAC-IN-51 is an HDAC inhibitor.Formula:C27H24N4O2Purity:98.85%Color and Shape:SolidMolecular weight:436.51Obatoclax
CAS:Obatoclax (GX15-070), a pan-BCL-2 inhibitor (Ki 220 nM) induces autophagy, degrades cyclin D1, and has anti-cancer/antiparasitic properties.Formula:C20H19N3OPurity:99.44%Color and Shape:SolidMolecular weight:317.38RDR03871
CAS:RDR03871 is an MDM2 inhibitor.
Formula:C18H16ClF3N6Purity:97.78%Color and Shape:SolidMolecular weight:408.81ENMD-1068 HCl
CAS:ENMD-1068 HCl (ENMD 1068) is a PAR-2 antagonist. ENMD-1068 HCl inhibits the development of endometriosis in a mouse model.Formula:C15H29N3O2Purity:99.91%Color and Shape:SolidMolecular weight:283.41UA 62784
CAS:Blocks microtubule growth, spurs cell apoptosis, enhances vinblastine's effect in HeLa cells, mistakenly seen as CENP-E ATPase inhibitor.Formula:C23H15NO3Color and Shape:SolidMolecular weight:353.37HI5
CAS:HI5: potent tubulin/IDO inhibitor, IC50 70 nM (HeLa), blocks kynurenine, G2/M arrest, spurs T cell activity, & triggers apoptosis.Formula:C42H43N5O8Color and Shape:SolidMolecular weight:745.82PDPOB
CAS:PDPOB, a phenyl carboxylic acid derivative, may protect neurons from ischemic damage by reducing mitochondrial issues, oxidative stress, and cell death.Formula:C15H20O5Color and Shape:SolidMolecular weight:280.327DG
CAS:7DG is a selective inhibitor of protein kinase R (PKR).Formula:C26H30O5Color and Shape:SolidMolecular weight:422.51GLS1 Inhibitor-4
CAS:GLS1 Inhibitor-4 (41e) has 11.86 nM IC50, strong binding, disrupts glutamine metabolism, induces apoptosis, and shows antitumor effects.Formula:C29H27F3N10O2S2Purity:98%Color and Shape:SolidMolecular weight:668.72EGFR-IN-88
CAS:EGFR-IN-88 (Compound 4i), an EGFR inhibitor with an IC50 of 87 nM, exhibits cytotoxic effects on A549 cells at an IC50 of 3.902 μM and can induce cell apoptosisFormula:C22H18Cl2N4O2SPurity:98%Color and Shape:SolidMolecular weight:473.37Atopaxar Hydrobromide
CAS:Atopaxar, a reversible PAR-1 thrombin receptor antagonist, interferes with platelet signaling.Formula:C29H39BrFN3O5Purity:98%Color and Shape:SolidMolecular weight:608.54Melflufen
CAS:Melflufen, a dipeptide prodrug of Melphalan, is an alkylating agent with strong antitumor activity in MM, causing DNA damage and cytotoxicity.Formula:C24H30Cl2FN3O3Purity:97.056%Molecular weight:498.42MPT0B214
CAS:MPT0B214, a potent microtubule inhibitor, disrupts tubulin polymerization and kills various cancer cells, including drug-resistant types.Formula:C20H20N2O5Color and Shape:SolidMolecular weight:368.38PD-1/PD-L1-IN-29
CAS:PD-1/PD-L1-IN-29 (S4-1) is a potent inhibitor of the PD-1/PD-L1 interaction, with an IC50 value of 6.1 nM.Formula:C26H24N2O6Color and Shape:SolidMolecular weight:460.48Docetaxel trihydrate
CAS:Docetaxel trihydrate (RP-56976 Trihydrate) is an antineoplastic agent that has a unique mechanism of action as an inhibitor of cellular mitosis.Formula:C43H59NO17Purity:98.68% - >99.99%Color and Shape:White Crystalline PowderMolecular weight:861.952,5-Dihydroxybiphenyl
CAS:2,5-Dihydroxybiphenyl: a small molecule that induces trichothiodystrophy A protein dimerization, modulating TFIIH activity.
Formula:C12H10O2Purity:99.66%Color and Shape:White To Grey-Brownish PowderMolecular weight:186.21MPT0B392
CAS:MPT0B392 is an orally active quinoline derivative, induces c-Jun N-terminal kinase (JNK) activation.Formula:C19H20N2O6SColor and Shape:SolidMolecular weight:404.44673-A
CAS:673-A inhibits ALDH1A, depletes ovarian CSCs, induces necroptosis, and reverses chemo resistance.Formula:C15H13NOColor and Shape:SolidMolecular weight:223.27AZD-5991 Racemate
CAS:AZD-5991 Racemate is the racemate of AZD-5991. (Rac)-AZD-5991 is a novel Mcl-1 inhibitor induces upregulation of BCL2,BCL-XL, CMYC and MCL1 in AML cell lines.Formula:C35H34ClN5O3S2Color and Shape:SolidMolecular weight:672.26Quinate
CAS:Quinate: oral antiarrhythmic, inhibits P450db, blocks K+ channels (IC50 19.9 μM), used in malaria research.Formula:C26H36N2O9Color and Shape:SolidMolecular weight:520.579Mcl1-IN-11
CAS:Mcl1-IN-11 (Compound G) is a selective Mcl-1 inhibitor, less potent at Bcl-2, with Kis of 0.06 and 4.2 μM, respectively.Formula:C38H41N3O5S2Purity:98%Color and Shape:SolidMolecular weight:683.88PDE4-IN-10
CAS:PDE4-IN-10 (7a), potent PDE4B inhibitor, IC50 7.01μM; selective, stable, TNF-α blocking, non-toxic in vitro.Formula:C18H13NColor and Shape:SolidMolecular weight:243.3ARN5187
CAS:ARN5187, a lysosomal REV-ERB β ligand, inhibits transcription and autophagy, shows efficacy, cytotoxicity, and induces apoptosis.Formula:C24H32FN3OColor and Shape:SolidMolecular weight:397.53K145
CAS:K145: Selective, oral SphK2 inhibitor, IC50 4.3 μM, Ki 6.4 μM, promotes cell apoptosis, strong antitumor effect, inactive against SphK1/other kinases.Formula:C18H24N2O3SPurity:98%Color and Shape:SolidMolecular weight:348.46QTX125
CAS:QTX125: potent, selective HDAC6 inhibitor with strong antitumor effects.Formula:C23H19N3O5Color and Shape:SolidMolecular weight:417.41Topoisomerase II inhibitor 7
CAS:Topoisomerase II inhibitor 7 halts cell division and induces apoptosis, targeting topoisomerase II alpha with a 3.19 μM IC50.Formula:C32H28BrN5O5SColor and Shape:SolidMolecular weight:674.56ATX inhibitor 13
CAS:ATX inhibitor 13: orally active, IC50 3.4 nM, halts RAW264.7 cells at G2, curbs growth/migration, prompts apoptosis, suppresses tumors.Formula:C31H35Cl2N5O3Color and Shape:SolidMolecular weight:596.55TNF-α-IN-10
CAS:TNF-α-IN-10 (compound 8a) acts as an inhibitor of IL-6 and TNF-α, demonstrating anti-inflammatory activity [1].Formula:C17H14O4Color and Shape:SolidMolecular weight:282.29Metaproterenol
CAS:Metaproterenol also has anti-inflammatory activity. Metaproterenol is a direct-acting sympathomimetic and a β2-adrenergic receptor (β2AR) agonist (IC50: 68 nM).Formula:C11H17NO3Purity:98%Color and Shape:SolidMolecular weight:211.26Aurora kinase-IN-1
Aurora kinase-IN-1: potent aurora kinase inhibitor, alters G1 cycle proteins, induces G1/S arrest and apoptosis, potential chemotherapy lead.Formula:C30H25Br2N3O5Color and Shape:SolidMolecular weight:667.34CCT128930
CAS:'CCT128930, potent Akt2 inhibitor (IC50=6 nM), 28x more selective over PKA.'Formula:C18H20ClN5Purity:99.07% - 99.18%Color and Shape:SolidMolecular weight:341.84Ref: TM-T6303
2mg39.00€5mg62.00€10mg88.00€25mg166.00€50mg259.00€100mg388.00€200mg617.00€1mL*10mM (DMSO)67.00€Anticancer agent 66
CAS:Anticancer agent 66, a ciprofloxacin analog, triggers apoptosis in MCF-7 cells.Formula:C26H23Cl2FN6O2S2Color and Shape:SolidMolecular weight:605.53Apoptosis inducer 10
CAS:Apoptosis inducer 10 is a potent apoptosis inducer with anti-proliferative activity.Formula:C27H46N2O2Color and Shape:SolidMolecular weight:430.67Estramustine phosphate
CAS:Estramustine phosphate can be used to treat prostatic neoplasms; also has radiation protective properties.Formula:C23H32Cl2NO6PColor and Shape:SolidMolecular weight:520.38MI-192
CAS:MI-192: Selective HDAC2/3 inhibitor, IC50=30/16 nM, induces apoptosis in myeloid leukemia, potential in leukemia/anti-stroke treatment.Formula:C24H21N3O2Color and Shape:SolidMolecular weight:383.44MIR002
CAS:MIR002: an oral POLA1/HDAC11 inhibitor with antitumor effects, enhances p53/p21, causes G1/S arrest, and triggers apoptosis.Formula:C27H29NO5Color and Shape:SolidMolecular weight:447.52bpV(phen)
CAS:bpV(phen) is a potent protein tyrosine phosphatase (PTP) and PTEN inhibitor (IC50s: 343 nM, 920 nM, and 38 nM for PTP-β, PTP-1B, and PTEN).Formula:C12H8KN2O5VPurity:98%Color and Shape:SolidMolecular weight:350.24SAHA-OH
CAS:SAHA-OH selectively inhibits HDAC6 (IC50 = 23 nM) with 10-47x preference over HDACs 1, 2, 3, 8, and reduces inflammation and macrophage apoptosis.Formula:C15H22N2O4Purity:98%Color and Shape:SolidMolecular weight:294.35NSC745885
CAS:NSC745885, Antitumor agent, downregulates EZH2 via proteasomal degradation, toxic to drug-resistant cancer lines, for bladder and oral cancer.Formula:C14H6N2O2SPurity:98%Color and Shape:SolidMolecular weight:266.27Erbstatin
CAS:Erbstatin is a tyrosine-protein kinase inhibitor. When combined with foroxymithine, it has antineoplastic activity against L-1210 leukemia.Formula:C9H9NO3Color and Shape:SolidMolecular weight:179.17BI-0282
CAS:BI-0282 (Compound 1) is a potent inhibitor of the MDM2-p53 interaction.Formula:C30H23Cl2FN4O4Color and Shape:SolidMolecular weight:593.43Antitumor agent-45
CAS:Antitumor agent-45 has an inhibitory effect on c-Met expression and is able to block A549 cells in the G0/G1 and G2/M phases and induce apoptosis.Formula:C28H17BrFN5O3Color and Shape:SolidMolecular weight:570.37HSP90-IN-13
CAS:HSP90-IN-13 (5k): potent HSP90 inhibitor, IC50 25.07 nM, targets EGFR/VEGFR-2/Topo-2, blocks MCF-7 G2/M cycle, induces apoptosis.Formula:C26H21N5O3SColor and Shape:SolidMolecular weight:483.54PI3K/Akt/mTOR-IN-3
CAS:PI3K/Akt/mTOR-IN-3 is a powerful inhibitor, halting MCF-7, HeLa, and HepG2 cell migration and triggering S phase arrest and apoptosis.Formula:C34H51NO2Color and Shape:SolidMolecular weight:505.77Bcl-2/Mcl-1-IN-2
CAS:Bcl-2/Mcl-1-IN-2 is a Bcl-2 (Ki: 4.70 μM) and Mcl-1 (Ki: 0.88 μM) inhibitor.Bcl-2/Mcl-1-IN-2 can be used in cancer research.Formula:C26H24ClNO3Color and Shape:SolidMolecular weight:433.93RI-962
CAS:RI-962 is a potent and selective inhibitor of RIPK1 that protects cells from necrotic apoptosis by inhibiting RIPK1, RIPK3, and MLKL phosphorylation.Formula:C28H28N6O2Purity:99.39%Color and Shape:SoildMolecular weight:480.56AV123
CAS:AV123, a RIPK1 inhibitor, non-cytotoxic, IC50: 12.12 μM; blocks TNF-α necroptosis (EC50: 1.7 μM) not apoptosis; useful in necrosis-related disease studies.Formula:C11H14N4O2Color and Shape:SolidMolecular weight:234.25Nafamostat hydrochloride
CAS:Nafamostat hydrochloride is a synthetic serine protease inhibitor and is an anticoagulant.Formula:C19H19Cl2N5O2Purity:98%Color and Shape:SolidMolecular weight:420.29Anticancer agent 83
CAS:Anticancer agent 83: potent, GI50 0.15 mM against LOX IMVI, reduces mitochondria potential, DNA damage, induces leukemia apoptosis.Formula:C20H19N5OSColor and Shape:SolidMolecular weight:377.46ZDLD13
CAS:ZDLD13, a β-carboline, inhibits CDK4/CycD3, halts HCT116 tumor growth, and induces apoptosis with IC50=0.38μM.Formula:C18H14N4OColor and Shape:SolidMolecular weight:302.33c-Met-IN-14
CAS:c-Met-IN-14: selective c-Met kinase inhibitor, IC50 2.89 nM, anticancer, stops G2/M phase, induces A549 cell apoptosis.Formula:C34H38ClFN4O7SColor and Shape:SolidMolecular weight:701.2LLP-3
CAS:Survivin inhibitor LLP-3 induces apoptosis in glioma cells by blocking Ran interaction; halts glioblastoma growth. IC50 = 31 μM.Formula:C32H23ClN2O4Color and Shape:SolidMolecular weight:534.99Antioxidant agent-5
CAS:Antioxidant agent-5 (D-6) curbs oxLDL effects, ROS, NF-κB movement, apoptosis in VECs; boosts Nrf2/HO-1; protects endothelium.Formula:C24H24N6OColor and Shape:SolidMolecular weight:412.49AG-024322
CAS:AG-024322 is a pan-CDK inhibitor with antitumor activity, induces apoptosis, and can be used in the study of metabolic diseases.Formula:C23H20F2N6Purity:98.53%Color and Shape:SolidMolecular weight:418.44SCH529074
CAS:SCH529074 is a selective activator of p53 (Ki = 1 μM) and can be used in studies about non-small-cell lung carcinoma.Formula:C31H36Cl2N6Purity:99.57%Color and Shape:SolidMolecular weight:563.56Ref: TM-T37042
1mg34.00€2mg43.00€5mg60.00€10mg99.00€25mg208.00€50mg310.00€100mg444.00€1mL*10mM (DMSO)72.00€Anticancer agent 77
CAS:Anticancer agent 77 exhibits anticancer effects and can be used extensively in synthetic and medicinal chemistry studies.Formula:C25H30BrN7Color and Shape:SolidMolecular weight:508.46AS1708727
CAS:AS1708727 is an orally bioavailable FOXO1 inhibitor that reduces plasma glucose and triglyceride levels in diabetic mice.Formula:C24H24Cl2N2O2Color and Shape:SolidMolecular weight:443.37Cl-amidine
CAS:Cl-amidine, an oral PAD inhibitor (IC50: 0.8-6.2 μM for PAD1/3/4), induces apoptosis in cancer cells.Formula:C14H19ClN4O2Purity:98%Color and Shape:SolidMolecular weight:310.78HLI98C
CAS:HLI98C is a HDM2 ubiquitin ligase inhibitor with anti-tumor activity.Formula:C17H9ClN4O4Color and Shape:SolidMolecular weight:368.73Shield-2
CAS:Shield-2 is a potent FKBP-derived destabilizing domain stabilizing ligand.Formula:C35H51N3O7Purity:98%Color and Shape:SolidMolecular weight:625.8Metoprolol fumarate
CAS:Metoprolol fumarate (CGP 2175C): selective β1-blocker with anti-inflammatory, antitumor, anti-angiogenic effects.Formula:C34H54N2O10Color and Shape:SolidMolecular weight:650.8GSK-345931A
CAS:GSK-345931A, Potent oral RIP2 inhibitor, suppresses pro-inflammatory cytokines, for autoimmune disease studies.Formula:C22H19ClNNaO3Color and Shape:SolidMolecular weight:403.83Alteminostat
CAS:Alteminostat is used as a histone deacetylase inhibitor and is an antineoplastic drug candidate.Formula:C27H36N6O3Color and Shape:SolidMolecular weight:492.61Topoisomerase II inhibitor 10
CAS:Topoisomerase II inhibitor 10 is a potent inhibitor of topoisomerase II (IC50: 7.45 μM).Formula:C27H20N6O7SColor and Shape:SolidMolecular weight:572.55DBIBB
CAS:DBIBB: non-lipid LPA2 receptor agonist, treats acute radiation syndrome, aids in organic synthesis/drug research.Formula:C23H20N2O6SPurity:98.49% - 99.1%Color and Shape:SolidMolecular weight:452.48Ref: TM-T22070
1mg42.00€5mg93.00€10mg134.00€25mg264.00€50mg378.00€100mg553.00€500mg1,111.00€1mL*10mM (DMSO)93.00€BLM-IN-2
BLM-IN-2: BLM inhibitor, IC50=0.8 μM; hinders CRC cell growth, invasion, cycle arrest, and death.Formula:C33H38BrFN4OColor and Shape:SolidMolecular weight:605.58SIRT6 activator 12q
CAS:SIRT6 activator 12q: potent, selective, oral; IC50 - SIRT1: 171.20μM, SIRT6: 0.58μM; halts cell growth/migration, induces apoptosis, G2 arrest, anticancer.Formula:C31H22N2O2Color and Shape:SolidMolecular weight:454.52CEP-1612
CAS:CEP-1612 inhibits protein breakdown, regulates cell cycles, apoptosis, boosts p21/p27 expression, and curbs lung cancer growth.Formula:C35H53N7O7Color and Shape:SolidMolecular weight:683.84SKLB0565
CAS:SKLB0565 inhibits tubulin and colorectal cancer growth (IC50: 0.012-0.081 μM), causes G2/M arrest, triggers apoptosis, and prevents HUVEC migration.Formula:C20H25ClN6OColor and Shape:SolidMolecular weight:400.91Tubulin polymerization-IN-24
CAS:HMBA (Tubulin-IN-24) inhibits tubulin assembly, boosts GTP hydrolysis, induces apoptosis, and arrests G2/M phase in MCF-7 cells.Formula:C22H16O3Color and Shape:SolidMolecular weight:328.36MI-63
CAS:MI-63 is a potent, specific, non-peptide inhibitor of the MDM2-p53 interaction.Formula:C29H35Cl2FN4O3Color and Shape:SolidMolecular weight:577.52p-nitro-Pifithrin-α
CAS:p-nitro-Pifithrin-α is a cell-permeable analog of pifithrin-α, a potent p53 inhibitor.Formula:C15H16BrN3O3SColor and Shape:SolidMolecular weight:398.27Ivaltinostat
CAS:CG-200745 is a potent inhibitor of HDAC. CG200745 induces apoptosis and also inhibits the deacetylation of histone H3 and tubulin.Formula:C24H33N3O4Purity:98%Color and Shape:SolidMolecular weight:427.54RET-IN-6
CAS:RET-IN-6 is a potent inhibitor of RET (IC50: 4.57 nM).Formula:C30H29N7Color and Shape:SolidMolecular weight:487.6Imofinostat
CAS:Imofinostat (MPT0E028) is a selective, orally available pan-HDAC inhibitor with IC₅₀ values of 53.0/106.2/29.5 nM against HDAC1/HDAC2/HDAC6 in HCT116 cells.Formula:C17H16N2O4SPurity:99.24%Color and Shape:SolidMolecular weight:344.38Ref: TM-T16131
1mg92.00€5mg192.00€10mg281.00€25mg595.00€50mg895.00€100mg1,558.00€1mL*10mM (DMSO)212.00€BPTQ
CAS:BPTQ: DNA intercalator, halts cancer cell growth by blocking S/G2/M phases.Formula:C17H16N4SPurity:98%Color and Shape:SolidMolecular weight:308.4HS56
CAS:HS56: ATP-competitive Pim/DAPK3 inhibitor, Ki: DAPK3 (0.26μM), Pim-3 (0.208μM), Pim-1 (2.94μM), Pim-2 (>100μM), reduces hypertension in mice.Formula:C13H8ClN5OSColor and Shape:SolidMolecular weight:317.75Nimustine
CAS:Nimustine: treats brain tumors, used with other drugs or radiotherapy for neoplasms.Formula:C9H13ClN6O2Color and Shape:SolidMolecular weight:272.69IV-23
CAS:IV-23 hinders cell growth, blocks M phase, induces apoptosis, and shows promise as an anticancer agent.Formula:C18H18BrNO4Purity:98%Color and Shape:SolidMolecular weight:392.24BMS-1166 hydrochloride
CAS:"Motixafortide blocks CXCR4 with 1 nM potency. BMS-1166 hinders PD-1/PD-L1, boosting T cell activation, IC50: 1.4 nM."Formula:C36H34Cl2N2O7Purity:98%Color and Shape:SolidMolecular weight:677.57HDAC-IN-39
CAS:HDAC-IN-39 inhibits HDAC1-3 (IC50: 1.07-2.27 μM), arrests G2/M phase, hinders microtubule polymerization, and is effective against drug-resistant cancers.Formula:C27H26N4O4SColor and Shape:SolidMolecular weight:502.58
